
Lillia in focus
News, research, and thought leadership at the intersection of AI
and chronic care
.png)
TIME names Lillia a top healthtech company
.png)
Lillia has been recognized by TIME among the World’s Top HealthTech Companies of 2025
Ranked in the AI & Data Analytics category with a ‘Very High’ performance indicator, this milestone highlights our global impact at the intersection of AI-driven insights and human-centered care
.png)
Lillia secures $1.7M grant to advance AI-powered chronic care
.png)
Lillia unveils its AI platform and digital twin technology to transform chronic disease management
Backed by a $1.7M QRDI Council grant and partnerships with 20 institutional clients, Lillia has already supported over 40,000 individuals across GCC and India, paving the way for global expansion and precision, AI-driven care
.png)
PHCC, Qatar: Largest diabetes management study in GCC
​
Published by American Diabetes Association (ADA) cohort of 633 patients across 27 Primary Health Care Corporation (PHCC) clinics
.png)
Outcome highlights
-
Reduction in HbA1c:
0.91% reduction for patients with initial HbA1c ≥ 8 -
Reduction in blood pressure:
7.84% reduction in systolic blood pressure for patients with initial BP ≥ 130/80 -
Reduction in cholesterol:
0.81 mmol/L reduction in total cholesterol for patients with cholesterol levels ≥ 5.18 mmol/L -
Reduction in weight:
0.72% reduction in BMI for patients with initial BMI ≥ 25
.png)
India: Large-scale diabetes management study
​
Published by American Diabetes Association (ADA) cohort of 808 patients across 50 cities in India
.png)
Outcome highlights
-
Reduction in HbA1c:
1.10% reduction for 808 patients
​
-
Reduction in HbA1c (uncontrolled
diabetes):
2.18% reduction for patients with
initial HbA1c ≥ 9
​
-
Increase in time in range (TIR):
7.16% increase for patients with
initial TIR of 40.3% ± 31%
.png)
Case Study: Leading clinic chain in India
​
Obesity and Diabetes Management Program
.png)
Outcome highlights
-
Reduction in HbA1c:
1.40% average reduction
​
-
Reduction in BMI:
3.35 average reduction for most compliant users
​
-
Reduction in weight:
3.50kg average reduction
Media features

Our approach
Chronic conditions drive most healthcare costs, yet care delivery remains fragmented and reactive.
Lillia transforms this model, connecting data, devices, and human expertise through AI to enable proactive, continuous, and personalized care at scale.
01
Evidence of improved adherence and outcomes
02
Expertise in AI-powered, digital end-to-end chronic care workflows
03
Trusted by providers and payers globally


